Literature DB >> 6616497

Phase I-II evaluation of acronine in patients with multiple myeloma.

J H Scarffe, A R Beaumont, D Crowther.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6616497

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  5 in total

1.  Synthesis and anti-proliferative activity of 2-hydroxy-1,2-dihydroacronycine glycosides.

Authors:  S Mitaku; A L Skaltsounis; F Tillequin; M Koch; Y Rolland; A Pierré; G Atassi
Journal:  Pharm Res       Date:  1996-06       Impact factor: 4.200

2.  In vitro activities of furoquinoline and acridone alkaloids against Plasmodium falciparum.

Authors:  L K Basco; S Mitaku; A L Skaltsounis; N Ravelomanantsoa; F Tillequin; M Koch; J Le Bras
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

Review 3.  Anticancer Alkaloids from Trees: Development into Drugs.

Authors:  Tasiu Isah
Journal:  Pharmacogn Rev       Date:  2016 Jul-Dec

Review 4.  Protein Recognition in Drug-Induced DNA Alkylation: When the Moonlight Protein GAPDH Meets S23906-1/DNA Minor Groove Adducts.

Authors:  Gaëlle Savreux-Lenglet; Sabine Depauw; Marie-Hélène David-Cordonnier
Journal:  Int J Mol Sci       Date:  2015-11-05       Impact factor: 5.923

5.  Boron Trifluoride Etherate Promoted Microwave-Assisted Synthesis of Antimalarial Acridones.

Authors:  Papireddy Kancharla; Rozalia A Dodean; Yuexin Li; Jane X Kelly
Journal:  RSC Adv       Date:  2019-12-20       Impact factor: 3.361
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.